MARK2 and renal carcinoma: It is hypothesized that aspartame may influence the migratory behavior of renal cancer cells by modulating the PAR1/EGFR-related pathway, thereby providing a foundation for elucidating the molecular mechanisms underlying KIRP and for the development of potential therapeutic targets.